Canadian Pharmaceuticals & Biotech Most Popular Stocks

Medicenna Therapeutics

Market Cap: CA$82.6m

A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.

NurExone Biologic

Market Cap: CA$82.4m

A pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries.

Decibel Cannabis

Market Cap: CA$77.9m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

MTL Cannabis

Market Cap: CA$75.8m

Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada.

iAnthus Capital Holdings

Market Cap: CA$67.8m

Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.

Sona Nanotech

Market Cap: CA$64.3m

Operates as a nanotechnology life sciences company.

C21 Investments

Market Cap: CA$63.6m

An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.

Sernova Biotherapeutics

Market Cap: CA$60.8m

Operates as a clinical-stage biotechnology company in Canada.

Covalon Technologies

Market Cap: CA$58.9m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

ZYUS Life Sciences

Market Cap: CA$50.8m

Manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union.

FLUENT

Market Cap: US$31.9m

Through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.

Rubicon Organics

Market Cap: CA$44.3m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

Defence Therapeutics

Market Cap: CA$43.8m

Develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases.

Charlotte's Web Holdings

Market Cap: CA$41.4m

Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products.

Gemina Laboratories

Market Cap: CA$38.3m

A biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada.

Thiogenesis Therapeutics

Market Cap: CA$36.8m

A clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs.

Microbix Biosystems

Market Cap: CA$36.3m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

MediPharm Labs

Market Cap: CA$35.8m

Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.

Optimi Health

Market Cap: CA$34.3m

Operates as a GMP-certified pharmaceutical drug manufacturing company in Canada.

PharmaTher Holdings

Market Cap: CA$34.1m

A specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes.

Simply Solventless Concentrates

Market Cap: CA$31.8m

Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.

Resverlogix

Market Cap: CA$30.1m

A late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses.

Avicanna

Market Cap: CA$29.5m

A commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets in Canada and internationally.

Voyageur Pharmaceuticals

Market Cap: CA$29.4m

Engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah.

1CM

Market Cap: CA$28.8m

Operates as a multi-jurisdictional cannabis company in Canada.

Greenway Greenhouse Cannabis

Market Cap: CA$26.5m

Engages in the cultivation, processing, sale, bulk package, and wholesale of dry bud cannabis.

BriaCell Therapeutics

Market Cap: CA$26.3m

A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.

Telescope Innovations

Market Cap: CA$24.6m

A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.

Devonian Health Group

Market Cap: CA$23.0m

Engages in the development of botanical drugs.

Rapid Dose Therapeutics

Market Cap: CA$22.6m

A life sciences company, provides drug delivery technologies in Canada.

Light AI

Market Cap: CA$22.3m

A healthcare technology company, focuses on developing artificial intelligence health diagnostic solutions designed to differentiate between bacterial and viral infections at point-of-care facilities.

Hemostemix

Market Cap: CA$18.4m

A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.

Ayr Wellness

Market Cap: CA$18.1m

Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods.

PreveCeutical Medical

Market Cap: CA$17.6m

A health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.

Red White & Bloom Brands

Market Cap: CA$16.5m

Manufactures and distributes cannabis products and accessories in the United States, Canada, and internationally.

Numinus Wellness

Market Cap: CA$16.1m

Provides psychedelic-assisted psychotherapy products and services in Canada and the United States.